SHL Telemedicine (SHMLF) reports completion of rights offering and capital boost

Rhea-AI Filing Summary

SHL Telemedicine Ltd. filed a Form 6-K to inform investors that it has successfully completed a rights offering and related capital increase. The company reports that this was announced in a press release dated December 3, 2025, titled “SHL Telemedicine successfully completes rights offering and capital increase,” which is attached to the report as an exhibit. The filing is signed by the Chief Financial Officer, Lior Haalman, on behalf of the company.

Form 6-K: How Foreign Companies Report to the SEC →

_{UNITED STATES}

_{SECURITIES AND EXCHANGE COMMISSION}

Washington, D.C. 20549

_{FORM 6-K}

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2025

Commission File Number: 001-41641

SHL TELEMEDICINE LTD.

(Translation of registrant’s name into English)

 90 Yigal Alon Street

Tel Aviv 67891, Israel

(Address of principal executive offices)

_____________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒            Form 40-F ☐ 

EXPLANATORY NOTE

On December 3, 2025, SHL Telemedicine Ltd. issued a press release titled “SHL Telemedicine successfully completes rights offering and capital increase”, a copy of which is furnished herewith as Exhibit 99.1, and which is incorporated by reference herein.

EXHIBIT INDEX

Exhibit Description

99.1 Press release, dated December 3, 2025, titled “SHL Telemedicine successfully completes rights offering and capital increase”

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SHL TELEMEDICINE LTD.
	By:	/s/ Lior Haalman
		Lior Haalman
		Chief Financial Officer

December 3, 2025

3

FAQ

What did SHL Telemedicine Ltd. (SHMLF) announce in this Form 6-K?

SHL Telemedicine Ltd. reported that it has successfully completed a rights offering and capital increase, as described in an attached press release dated December 3, 2025.

Where can investors find more details about SHL Telemedicine’s rights offering?

More details are contained in the press release titled “SHL Telemedicine successfully completes rights offering and capital increase”, which is furnished as Exhibit 99.1 and incorporated by reference.

Who signed the SHL Telemedicine Ltd. (SHMLF) Form 6-K?

The Form 6-K was signed on behalf of SHL Telemedicine Ltd. by Lior Haalman, Chief Financial Officer, on December 3, 2025.

What is the purpose of this SHL Telemedicine (SHMLF) Form 6-K filing?

The purpose is to furnish the press release announcing the successful completion of a rights offering and capital increase, making that information available to investors under U.S. securities rules.

Does this SHL Telemedicine Form 6-K include financial figures for the rights offering?

No specific financial amounts or terms of the rights offering or capital increase are described in the text provided, only that the transaction was successfully completed.

What type of issuer is SHL Telemedicine Ltd. (SHMLF) in this filing?

SHL Telemedicine Ltd. is identified as a foreign private issuer reporting on Form 6-K under the Securities Exchange Act of 1934.